Provides ReciBioPharm’s customers with access to NewBiologix’s Xcell-Eng-HEK293 cell lines for advanced therapies Complements and further expands ReciBioPharm’s AAV offering Achieves…Read More
You might also be interested in reading Sanuwave health targets 40%-50% Q2 revenue growth with strategic customer focus.